Prestige Biologics Receives Approval for Osong 2nd Campus Use... State-of-the-Art Biopharmaceutical Production Facility

Prestige Biologics Osong Campus 2 Main Building.

[Asia Economy Reporter Lee Gwan-joo] Prestige Biologics announced on the 31st that the main building of its Osong 2nd Campus in Chungbuk has obtained building use approval.

The main building of the 2nd Campus is a multi-purpose biopharmaceutical manufacturing facility with a total floor area of 24,790㎡ and six above-ground floors. It houses advanced antibody drug production rooms, QC (quality control) testing labs, and automated warehouses, incorporating the company's patented ALITA smart bio factory system.

Prestige Biologics plans to have a total antibody drug and vaccine production capacity of approximately 234,000 liters by combining the Osong 1st and 2nd Campuses.

Yang Jae-young, CEO of Prestige Biologics, said, "We are pleased to complete the main building of the 2nd Campus based on our outstanding engineering technology despite the COVID-19 situation. We will leap forward as a leading global pharmaceutical CMO company by establishing state-of-the-art biopharmaceutical manufacturing facilities at the 2nd Campus and providing customized contract manufacturing services tailored to our clients' needs."

This content was produced with the assistance of AI translation services.